This story has been updated from a previous version.

WaferGen Biosystems has raised $7 million in capital through a $5 million private placement by its Malaysian subsidiary and a $2 million loan agreement with Oxford Finance, the company said this week.

As part of the private placement, WaferGen's Malaysian subsidiary signed a purchase agreement with previous investor Malaysian Technology Development Corporation for a $5 million private placement of Series C-1 redeemable convertible preference shares.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.